SCIRIS

What SCIRIS does

SCIRIS is a London-headquartered, privately held healthcare communications and consultancy group serving global pharmaceutical companies. The group was formed through the consolidation of five specialist agencies — Porterhouse Medical Group, Porterhouse Insights, Indigo Medical, Wedgewood Health, and Source Health Economics — and now employs more than 300 people across the United Kingdom and North America. SCIRIS delivers bespoke programmes spanning scientific and omnichannel communications, behavioural-science-driven insights, medical compliance, HEOR and market access consultancy, and global brand campaign execution, targeting enterprise pharma clients across all therapeutic categories and phases of brand development.

The operating model is a multi-agency platform in which each subsidiary retains its individual culture, brand identity, and client-facing presence while collaborating under unified group leadership led by Chief Executive Officer Dan Spacie. Revenue is generated through professional services engagements — principally project-based and retainer work — sold directly to enterprise pharmaceutical clients. The underlying technology stack is service-led rather than product-led, with proprietary value concentrated in domain expertise, behavioural-science methodology, HEOR and health-economic modelling capability, and regulatory-compliant medical writing rather than in a discrete software platform.

SCIRIS has pursued an aggressive inorganic growth strategy, completing approximately six agency acquisitions over the two years preceding January 2023, including the January 2023 acquisition of UK-based Source Health Economics. The company is privately held with no disclosed external funding rounds, no named institutional investors, and no public revenue or pricing disclosures, leaving the ownership structure and financial scale inferred rather than confirmed.

Name

SCIRIS

Legal name

SCIRIS GROUP LIMITED

Website

https://sciris.com

Company type

Private

Operating status

Operating

Headcount range

251–500 employees

Short description

SCIRIS is a privately held London-headquartered healthcare communications and consultancy group operating a five-agency platform (Porterhouse Medical Group, Porterhouse Insights, Indigo Medical, Wedgewood Health, Source Health Economics) that delivers scientific communications, HEOR, medical compliance, brand strategy, and behavioural insights to global pharmaceutical clients across the UK and North America.

Ownership category

akta.pro rank

Product category

Healthcare Communications & Consultancy

NAICS

Advertising, Public Relations, and Related Services (5418)

SIC

Services-Health Services (8000)

akta.pro primary industry

Healthcare & Life Sciences PR (BPAFADAJ)

akta.pro secondary industry

Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)

Keywords

• Healthcare communications services
• Pharmaceutical consultancy
• Medical writing
• HEOR consultancy
• Biopharma brand strategy

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Healthcare Communications Services: SCIRIS generates revenue through providing professional services to the pharmaceutical industry, including strategic scientific communications, medical writing, brand strategy, and compliance services. The group operates on a bespoke programme basis, suggesting project-based and potentially retainer arrangements with pharmaceutical clients.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

SCIRIS is a healthcare communications and consultancy group that provides bespoke programmes in healthcare communications, creative and brand strategy, medical compliance, HEOR (health economics and outcomes research) consultancy, and insights to the global pharmaceutical industry. Operating through five specialized agencies (Porterhouse Medical Group, Porterhouse Insights, Indigo Medical, Wedgewood Health, and Source Health Economics), the group supports pharmaceutical product commercialisation across all therapeutic categories and all phases of brand development, employing more than 300 people in the UK and North America.

Product overview

SCIRIS is a healthcare communications group operating as a platform of five independent agencies joined under unified leadership. The group offers bespoke programmes in healthcare communications (Porterhouse Medical Group), creative and brand strategy (Wedgewood Health), medical compliance (Indigo Medical), HEOR consultancy (Source Health Economics), and insights (Porterhouse Insights). The agencies maintain individual culture and identity while benefiting from collaborative capabilities across therapeutic categories and all phases of brand development.

Differentiator

Problem solved

Functional benefit

Brands

• Porterhouse Medical Group: Global, strategic, scientific communications group providing omnichannel communication services to the pharmaceutical industry worldwide
• Porterhouse Insights
• Indigo Medical Communications
• Wedgewood Health
• Source Health Economics

Products and services

• Porterhouse Medical Group Global, strategic, scientific communications group providing powerful, insight-driven, omnichannel communication services to the pharmaceutical industry worldwide, focusing on the successful commercialisation of products and technologies that address unmet health needs.
• Porterhouse Insights Global research consultancy driven to generate actionable insights for biopharmaceutical clients using behavioural science, optimising decision-making through clear insights across the product life cycle and communicating them via compelling narratives.
• Indigo Medical Communications Medical communications agency combining strategy, science, skilled writing, and creativity to deliver solutions that anticipate client needs, with an acute understanding of compliance to identify code requirements early and navigate issues throughout creative development.
• Wedgewood Health Best-in-class commercial biopharma agency with experience in global marketing, with science, strategy, and creative teams working together to develop and execute compelling brand campaigns that exceed goals and move market share.
• Source Health Economics HEOR consultancy actively focused on optimising market access for new healthcare interventions, delivering technical excellence in real-world evidence generation and synthesis, health economic modelling, statistics, health technology assessment submissions, and value communication.

Quantifiable outcome

• Successful delivery of healthcare communications programmes across all therapeutic categories and brand development phases.

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Source Health EconomicscoreStrategic or Co-development Partner · 16 January 2023SCIRIS acquired UK-based Source Health Economics in January 2023, enhancing its services in health economics and outcomes research. This acquisition was part of SCIRIS's rapid expansion including six agency acquisitions over two years, strengthening its global healthcare communications capabilities with HEOR consultancy services including real-world evidence generation, health economic modelling, statistics, and health technology assessment submissions.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Publicis Health Communications: Largest global healthcare communications network under Publicis Groupe, spanning medical communications, PR, and brand activation across pharma clients globally - directly comparable to SCIRIS's full-service healthcare comms offering, but with significantly greater global scale.
• Omnicom Health Group: Healthcare division of Omnicom Group consolidating multiple healthcare creative, medical communications, and consulting agencies under one P&L - a direct comp to SCIRIS's multi-agency federated model and end-to-end pharma service model.
• IPG Health: Interpublic Group's healthcare marketing network combining creative, scientific communications, and medical education agencies - comparable to SCIRIS in serving global pharma across therapeutic categories and lifecycle phases.
• Havas Health & You: Havas's global health and wellness network offering brand strategy, medical communications, and HEOR support - parallel to SCIRIS's mix of scientific communications (Porterhouse), brand (Wedgewood) and HEOR services.
• WPP (Health & Wellness): Global holding company whose WPP Health & Wellness vertical consolidates VMLY&R Health, Grey Health, Ogilvy Health, and other pharma-facing agencies - a top-tier incumbent against which SCIRIS competes for large pharma mandates.
• Medscape (WebMD Health Network): Largest medical professional education and communications platform targeting physicians globally - competes with SCIRIS for medical communications and scientific engagement budgets even though its delivery model (owned media) differs from SCIRIS's bespoke agency model.

Direct peers

• Fishawack Health: Multi-agency healthcare communications group built through acquisitions of medical communications, creative, and HEOR firms - structurally the closest mid-sized peer to SCIRIS's federated five-agency model.
• Evidera: Standalone HEOR and real-world evidence consultancy (now part of Thermo Fisher's PPD) - directly comparable to Source Health Economics and benchmark for SCIRIS's HEOR service line.
• CBPartners: Boutique HEOR, market access, and pricing consultancy serving global pharma - closely comparable to Source Health Economics within the SCIRIS group and a competitor for the same payer-engagement mandates.
• Cello Health (Biopharma): Pharma market research and healthcare communications group with HEOR and brand strategy capabilities - a comparable mid-sized multi-discipline healthcare services platform to SCIRIS.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/ScirisGroup
• LinkedInlinkedin.com/company/about
• Facebookfacebook.com/scirisgroup

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SCIRIS